List view / Grid view
HIV is a disease still common in sub-Saharan Africa despite global research since 1982. This article delves into the trends, opportunities and key players in HIV research, exploring future possibilities for treating the disease.
6 November 2018 | By PerkinElmer
This webinar outlined the fundamentals of a design process where an experimental analytics data workflow is being integrated into a more seamlessly interactive platform...
The mechanism our immune cells use to clear bacterial infections like tuberculosis might also be implicated in Parkinson's disease...
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
The human body’s peripheral nervous system could be capable of interpreting its environment and modulating pain, neuroscientists have established, after successfully studying how rodents reacted to stimulation.
GSK's top investigators explain why the data quality offered by Fluorescence lifetime detection technology for drug discovery applications is superior…
Pharma companies involved include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis, and Pfizer.
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Emma Walmsley will succeed Andrew Witty as GSK CEO when he retires on 31st March 2017, making her the first female CEO of a major pharmaceuticals company...
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
27 July 2016 | By Niamh Louise Marriott, Digital Content Producer
The investment will be used for manufacturing of new respiratory and biopharmaceuticals, to be exported outside the UK to global markets...
15 June 2016 | By Victoria White, Digital Content Producer
According to a study, genetic research in large-scale prospective biobank studies can significantly improve the drug development pipeline and reduce costs...
4 May 2016 | By Victoria White, Digital Content Producer
By expressing the genes involved in the production of pleuromutilin in a different type of fungus, researchers increased production by more than 2,000%...
12 February 2016 | By Victoria White
The latest report from the Review on Antimicrobial Resistance says that vaccines and other alternatives can play a vital role in tackling the rise of drug-resistant infections...
3 February 2016 | By Victoria White
The enhanced agreement will accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell immunotherapy targeting NY-ESO-1...
28 January 2016 | By Victoria White
The ADDoPT project addresses the key challenge of getting new innovative medicines to market in the quickest and most cost-effective way...
